| 24th Feb 2025 7:00 am |
RNS |
First-in-Human Treatment with HG-CT-1 |
| 19th Feb 2025 4:50 pm |
RNS |
Issue of convertible loan notes |
| 31st Jan 2025 9:35 am |
RNS |
Total Voting Rights |
| 8th Jan 2025 7:00 am |
RNS |
Placing to raise £340,000 |
| 2nd Jan 2025 7:00 am |
RNS |
Change of Company Secretary and Registered Office |
| 31st Dec 2024 7:00 am |
RNS |
Total Voting Rights |
| 30th Dec 2024 7:00 am |
RNS |
Opening of First Clinical Site |
| 19th Dec 2024 7:00 am |
RNS |
Ultrafast CAR-T Manufacturing |
| 10th Dec 2024 4:10 pm |
RNS |
Admission of New Ordinary Shares and New ISIN |
| 9th Dec 2024 1:30 pm |
RNS |
Result of Extraordinary General Meeting |
| 9th Dec 2024 7:00 am |
RNS |
Site Initiation Visit Completed |
| 6th Dec 2024 7:00 am |
RNS |
CBR Macrophage Delivery Update |
| 29th Nov 2024 7:00 am |
RNS |
Total Voting Rights |
| 22nd Nov 2024 12:49 pm |
RNS |
Notice of Extraordinary General Meeting |
| 22nd Nov 2024 7:00 am |
RNS |
IRB Approval for Phase I Clinical Trial |
| 11th Nov 2024 7:00 am |
RNS |
Institutional Investment |
| 30th Oct 2024 7:00 am |
RNS |
Schedule for Phase I Clinical Trial Opening |
| 2nd Oct 2024 11:19 am |
RNS |
Strategic Investment from Prevail Partners, LLC |
| 27th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 9th Sep 2024 7:00 am |
RNS |
FLT3 Assay Ready for Phase I Trials at MD Anderson |
| 2nd Sep 2024 7:00 am |
RNS |
CDX Development Update |
| 28th Aug 2024 7:00 am |
RNS |
Presentation at CBD S&T Conference |
| 27th Jun 2024 4:39 pm |
RNS |
Result of Annual General Meeting |
| 17th Jun 2024 7:00 am |
RNS |
Operations Update |
| 3rd Jun 2024 7:00 am |
RNS |
Posting of Annual Report & Notice of AGM |
| 25th Apr 2024 7:00 am |
RNS |
Final Results |
| 28th Mar 2024 7:00 am |
RNS |
Total Voting Rights |
| 29th Feb 2024 7:00 am |
RNS |
Placing to Raise US$4.2 million |
| 16th Feb 2024 7:00 am |
RNS |
CBR Brain Delivery |
| 14th Feb 2024 7:00 am |
RNS |
CBR Intranasal Delivery |
| 9th Feb 2024 7:00 am |
RNS |
FDA Consents to Phase I Trials of HEMO-CAR-T |
| 2nd Feb 2024 7:00 am |
RNS |
Approval and Issuance of U.S. Conditioning Patent |
| 16th Jan 2024 7:00 am |
RNS |
Submission of Complete Response to Clinical Hold |
| 8th Jan 2024 7:00 am |
RNS |
HEMO-CAR-T Process Qualification Run Completed |
| 28th Nov 2023 12:19 pm |
RNS |
Placing to Raise £534,375 |
| 27th Nov 2023 7:00 am |
RNS |
CBR Expanded to Treatment of Cancer |
| 15th Nov 2023 7:00 am |
RNS |
Lentivirus Re-manufacturing Completed |
| 31st Oct 2023 7:00 am |
RNS |
Total Voting Rights |
| 28th Sep 2023 12:28 pm |
RNS |
Half-year Report |
| 18th Sep 2023 7:00 am |
RNS |
Strategic Investment from Prevail Partners, LLC |
